Cancer Treatment Evaluation Program (CTEP) 2013 Spring Early Drug Development Meeting

CTEP 2013 Spring Early Drug Development Meeting is held on a semi-annual basis and is organized to enhance communication between NCI and the network of UO1 and NO1-funded investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel involved in oncology early drug development. The agenda is generated by CTEP staff and the Scientific Meeting Planning Task Force of the Investigational Drug Steering Committee and consists of a diverse spectrum of educational sessions, clinical trial presentations, keynote lectures, and closed meetings with UO1 and NO1 investigators. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.